Am J Surg

1. DOURADO J, Rogers P, Emile S, Wignakumar A, et al
   Predictors of nodal positivity in clinically under-staged patients with colon cancer: A National Cancer Database study and proposal of a predictive scoring system.
   Am J Surg. 2024 May 24:115777. doi: 10.1016/j.amjsurg.2024.115777.
   

   >> Share

   
   

   
   Ann Surg Oncol

2. BHUTIANI N, Ochiai K, Awiwi MO, Rodriguez-Bigas MA, et al
   Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes.
   Ann Surg Oncol. 2024 Jun 5. doi: 10.1245/s10434-024-15539.
   

   >> Share

   
   

   
   Anticancer Res

3. MOON SU, Lee JH, Shah M, Yoon S, et al
   RRM2 Is a CTNNB1 Transport Regulator Promoting Colon Cancer Progression.
   Anticancer Res. 2024;44:2471-2485.
   

   >> Share

   
   
4. TOREN W, Sasor A, Ansari D, Andersson R, et al
   ARHGAP4 as a Prognostic Biomarker for Colon Liver Metastases After Surgical Resection.
   Anticancer Res. 2024;44:2597-2604.
   

   >> Share

   
   
5. MATSUDA A, Yamada T, Takahashi G, Matsumoto S, et al
   Significance of Adjuvant Chemotherapy for Obstructive Colorectal Cancer After Stent Placement: A Multicenter Retrospective Study.
   Anticancer Res. 2024;44:2737-2745.
   

   >> Share

   
   
6. LIM SC, Lee TB, Han SI
   Caffeic Acid Enhances Anticancer Drug-induced Apoptosis in Acid-adapted HCT116 Colon Cancer Cells.
   Anticancer Res. 2024;44:2587-2595.
   

   >> Share

   
   

   
   BMC Cancer

7. BIYU H, Mengshan L, Yuxin H, Ming Z, et al
   A miRNA-disease association prediction model based on tree-path global feature extraction and fully connected artificial neural network with multi-head self-attention mechanism.
   BMC Cancer. 2024;24:683.
   

   >> Share

   
   
8. YOSHIMOTO T, Nishi M, Okikawa S, Yoshikawa K, et al
   Blue light irradiation inhibits the M2 polarization of the cancer-associated macrophages in colon cancer.
   BMC Cancer. 2024;24:664.
   

   >> Share

   
   
9. YE J, Ying J, Chen H, Wu Z, et al
   PPIH acts as a potential predictive biomarker for patients with common solid tumors.
   BMC Cancer. 2024;24:681.
   

   >> Share

   
   
10. AQUINO DE MORAES FC, Dantas Leite Pessoa FD, Duarte de Castro Ribeiro CH, Rodrigues Fernandes M, et al
    Trifluridine-tipiracil plus bevacizumab versus trifluridine-tipiracil monotherapy for chemorefractory metastatic colorectal cancer: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:674.
    

    >> Share

    
    
11. LI KZ, Liao XM, Li SQ, Wei HT, et al
    Identification and diagnostic potential of hsa_circ_101303 in colorectal cancer: unraveling a regulatory network.
    BMC Cancer. 2024;24:671.
    

    >> Share

    
    

    
    BMC Gastroenterol

12. ZHANG X, Liu S, Liu L, Zhu Z, et al
    Low Hartmann's procedure versus abdominoperineal resection for rectal cancer, a propensity score matching cohort study.
    BMC Gastroenterol. 2024;24:194.
    

    >> Share

    
    

    
    Cancer Lett

13. AGORKU DJ, Bosio A, Alves F, Strobel P, et al
    Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling.
    Cancer Lett. 2024;595:216985.
    

    >> Share

    
    
14. BIAN Y, Xu S, Gao Z, Ding J, et al
    m(6)A modification of lncRNA ABHD11-AS1 promotes colorectal cancer progression and inhibits ferroptosis through TRIM21/IGF2BP2/ FOXM1 positive feedback loop.
    Cancer Lett. 2024 Jun 3:217004. doi: 10.1016/j.canlet.2024.217004.
    

    >> Share

    
    

    
    Dis Colon Rectum

15. CHUNG KC, Wu KL, Su YL, Cheng KC, et al
    Outcomes of Robot-Assisted Versus Laparoscopic Surgery for Colorectal Cancer in Adults >/= 75 Years Old: A Propensity Score Matched Analysis of the US Nationwide Inpatient Sample.
    Dis Colon Rectum. 2024 Jun 7. doi: 10.1097/DCR.0000000000003374.
    

    >> Share

    
    

    
    Eur J Cancer

16. CHEN C, Feng YS, Wang Z, Gupta M, et al
    Organ-specific tumor dynamics predict survival of patients with metastatic colorectal cancer.
    Eur J Cancer. 2024;207:114147.
    

    >> Share

    
    

    
    Eur J Gastroenterol Hepatol

17. DUGGAN WP, Lenihan J, Clancy C, McNamara DA, et al
    The effect of implementing a transanal minimally invasive surgical programme for the local excision of early rectal neoplasia on outcomes in a tertiary referral rectal cancer centre.
    Eur J Gastroenterol Hepatol. 2024;36:861-866.
    

    >> Share

    
    

    
    Int J Colorectal Dis

18. ZHOU S, Yuan Q, Liu L, Wang K, et al
    Prediction of lymph node metastasis in T1 colorectal cancer based on combination of body composition and vascular invasion.
    Int J Colorectal Dis. 2024;39:84.
    

    >> Share

    
    
19. VIVAS LOPEZ A, Villar OG, Borda JG, Restrepo Nunez R, et al
    Low anterior resection with transanal transection and single-stapled anastomosis: technical aspects and initial results.
    Int J Colorectal Dis. 2024;39:85.
    

    >> Share

    
    
20. LIANG B, Xie S, Yu N, Xue X, et al
    Impact of lymph node retrieval on prognosis in elderly and non-elderly patients with T3-4/N+ rectal cancer following neoadjuvant therapy: a retrospective cohort study.
    Int J Colorectal Dis. 2024;39:86.
    

    >> Share

    
    
21. STROSE L, Sparn M, Klein M, Benigno L, et al
    Solitary fibrous tumor within the mesorectum: literature review based on a case report of resection by transanal minimally invasive surgery (TAMIS).
    Int J Colorectal Dis. 2024;39:87.
    

    >> Share

    
    

    
    J Clin Oncol

22. KAWAZOE A, Xu RH, Garcia-Alfonso P, Passhak M, et al
    Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study.
    J Clin Oncol. 2024 Jun 4:JCO2302736. doi: 10.1200/JCO.23.02736.
    

    >> Share

    
    

    
    J Natl Cancer Inst

23. RANSOHOFF DF
    Evaluating a blood test for Colon cancer screening: how simulation modeling can inform clinical policy making and research.
    J Natl Cancer Inst. 2024 Jun 6:djae125. doi: 10.1093.
    

    >> Share

    
    
24. NASCIMENTO DE LIMA P, Van Den Puttelaar R, Knudsen AB, Hahn AI, et al
    Characteristics of a cost-effective blood test for colorectal cancer screening.
    J Natl Cancer Inst. 2024 Jun 6:djae124. doi: 10.1093.
    

    >> Share

    
    

    
    J Surg Oncol

25. HERNANDEZ MC, Fan D, Sandhu J, Mahuron K, et al
    Recurrence patterns after complex multimodality therapy and hepatic arterial infusion for colorectal liver metastases: A reflection of biology and technique.
    J Surg Oncol. 2024;129:1254-1264.
    

    >> Share

    
    

    
    Lancet Oncol

26. LU Z, Tang X, Xing X
    Effect of multitarget faecal immunochemical testing on colorectal cancer screening strategies.
    Lancet Oncol. 2024;25:e226.
    

    >> Share

    
    

    
    N Engl J Med

27. CERCEK A
    Neoadjuvant Treatment of Mismatch Repair-Deficient Colon Cancer - Clinically Meaningful?
    N Engl J Med. 2024;390:2024-2025.
    

    >> Share

    
    
28. CHALABI M, Verschoor YL, Tan PB, Balduzzi S, et al
    Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer.
    N Engl J Med. 2024;390:1949-1958.
    

    >> Share

    
    

    
    PLoS One

29. MAHDOUANI M, Zhuri D, Sezginer Guler H, Hmida D, et al
    Functional analysis of MMR gene VUS from potential Lynch syndrome patients.
    PLoS One. 2024;19:e0304141.
    

    >> Share

    
    
30. FIRESTEIN R, Blander G, Michan S, Oberdoerffer P, et al
    Correction: The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth.
    PLoS One. 2024;19:e0305277.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

31. HUANG KB, Wang FY, Lu Y, Yang LM, et al
    Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis.
    Proc Natl Acad Sci U S A. 2024;121:e2404668121.
    

    >> Share

    
    

    
    World J Surg

32. GURUSAMY K, Leung J, Vale C, Roberts D, et al
    Cytoreductive surgery plus hyperthermic intraoperative peritoneal chemotherapy for people with peritoneal metastases from colorectal, ovarian or gastric origin: A systematic review of randomized controlled trials.
    World J Surg. 2024;48:1385-1403.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share